Safe Medicine Act

The Safe Medicine Act (HR 5575) aims to reduce U.S. dependence on foreign-manufactured generic drugs by requiring federal agencies to develop a strategy within 180 days to boost domestic production of 227 essential medicines and critical inputs identified by the FDA. It mandates that the FDA issue boxed warnings on drugs from countries with systemic contamination risks (like China or India) unless their labels already include such warnings. The bill also prevents waivers of domestic procurement preferences for these essential medicines under trade agreements. This targets medicines critical for public health emergencies, such as antibiotics and blood pressure drugs, to address supply chain vulnerabilities exposed by past contamination incidents.